Earnings Outlook For Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
Neurocrine Biosciences (NASDAQ:NBIX) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.98. The company's past performance shows a pattern of beating EPS estimates. However, the stock has been down 9.55% over the last 52-week period.
October 30, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Neurocrine Biosciences is expected to report an EPS of $0.98 in its upcoming earnings. Despite a history of beating EPS estimates, the stock has been down 9.55% over the last year.
The upcoming earnings report is highly relevant to Neurocrine Biosciences' stock. While the company has a history of beating EPS estimates, which could potentially boost the stock, the overall negative trend over the past year may dampen investor sentiment. Therefore, the short-term impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100